Moreover, whether and how CHCHD10 mutations alter the pathological landscape (that is, TDP-43 inclusions) of FTD–ALS spectrum diseases is completely unknown, and no FTD/ALS mutations other than S59L have been functionally characterized. The gene discussed is TARDBP; the disease is frontotemporal dementia.